Aarkstore.com announces, The Latest market research report is available inits vast collection:S.L.A. Pharma AG – Product Pipeline Review – 2012http://www.aarkstore.com/reports/S-L-A-Pharma-AG-Product-Pipeline-Review-2012-217914.htmlRSS link of Global Markets Directhttp://www.aarkstore.com/feeds/Global-Markets-Direct.xmlSummaryGlobal Market Direct’s pharmaceuticals report, “S.L.A. Pharma AG - Product PipelineReview - 2012” provides data on the S.L.A. Pharma AG’s research and developmentfocus. The report includes information on current developmental pipeline, completewith latest updates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, S.L.A. Pharma AG’s corporate website, SEC filings, investorpresentations and featured press releases, both from S.L.A. Pharma AG andindustry-specific third party sources, put together by Global Markets Direct’s team.Scope- S.L.A. Pharma AG - Brief S.L.A. Pharma AG overview including business description,key information and facts, and its locations and subsidiaries.- Review of current pipeline of S.L.A. Pharma AG human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.
Table of contents:List of Tables 4List of Figures 4S.L.A. Pharma AG Snapshot 5S.L.A. Pharma AG Overview 5Key Information 5Key Facts 5S.L.A. Pharma AG – Research and Development Overview 6Key Therapeutic Areas 6S.L.A. Pharma AG – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9S.L.A. Pharma AG – Pipeline Products Glance 10S.L.A. Pharma AG – Late Stage Pipeline 10Phase III Products/Combination Treatment Modalities 10S.L.A. Pharma AG Clinical Stage Pipeline Products 11Phase II Products/Combination Treatment Modalities 11S.L.A. Pharma AG – Drug Profiles 12Diltiazem 12Product Description 12Mechanism of Action 12R&D Progress 12Eicosapentaenoic Acid 14Product Description 14Mechanism of Action 14R&D Progress 14Metronidazole 16Product Description 16Mechanism of Action 16R&D Progress 16Nalcol 17Product Description 17Mechanism of Action 17R&D Progress 17Phenylephrine Hydrochloride Gel 18Product Description 18
Mechanism of Action 18List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview&PubId=&pagenum=1Proteo, Inc. – Product Pipeline Review – 2012Reata Pharmaceuticals, Inc. – Product Pipeline Review – 2012Recoly N.V. – Product Pipeline Review – 2012S.L.A. Pharma AG – Product Pipeline Review – 2012SBI Biotech Co., Ltd. – Product Pipeline Review – 2012Sentinel Oncology Limited – Product Pipeline Review – 2012Sentinel Oncology Limited – Product Pipeline Review – 2012SIFI Pharma – Product Pipeline Review – 2012Snowdon Inc. – Product Pipeline Review – 2012Stelic Institute & Co. – Product Pipeline Review – 2012SWITCH Biotech LLC – Product Pipeline Review – 2012
Teikoku Pharma USA, Inc. – Product Pipeline Review – 2012TetraLogic Pharmaceuticals – Product Pipeline Review – 2012Tranzyme Pharma, Inc. – Product Pipeline Review – 2012Unigene Laboratories, Inc. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports email@example.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: firstname.lastname@example.org